72.72

0.15% 0.11

Henry Schein Inc (HSIC)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Henry Schein Inc stock is traded at $72.72, with a volume of 3.10M. It is up +0.15% in the last 24 hours and down -6.07% over the past month. Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.

Previous Close:

$72.61

Open:

$72.76

24h Volume:

3.10M

Relative Volume:

2.11

Market Cap:

$8.28B

Revenue:

$13.18B

Net Income/Loss:

$419.00M

P/E Ratio:

22.24

EPS:

3.2704

Net Cash Flow:

$521.00M

1W Performance:

+2.68%

1M Performance:

-6.07%

6M Performance:

+1.81%

1Y Performance:

+1.65%

1-Day Range:

$71.50

$73.31

1-Week Range:

$68.70

$73.31

52-Week Range:

$61.95

$89.29

Henry Schein Inc Stock (HSIC) Company Profile

Name

Henry Schein Inc

Sector

Healthcare (1101)

Industry

Medical Distribution (12)

Phone

(631) 843-5500

Address

135 DURYEA RD, MELVILLE, NY

Employee

25,000

Twitter

@henryschein

Next Earnings Date

2026-05-05

Latest SEC Filings

HSIC's Discussions on Twitter

Compare HSIC vs MCK, COR, CAH, AHG

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HSIC Henry Schein Inc	72.72	8.27B	13.18B	419.00M	521.00M	3.2704
MCK Mckesson Corp	760.57	89.82B	403.43B	5.10B	5.41B	38.47
COR Cencora Inc	257.71	50.80B	328.68B	2.55B	1.56B	13.03
CAH Cardinal Health Inc	195.20	45.52B	250.74B	1.55B	4.39B	6.5398
AHG Akso Health Group Adr	1.73	1.75B	14.85M	-136.07M	7.25M	-0.4726

Henry Schein Inc Stock (HSIC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-16-26	Initiated	BTIG Research	Neutral
Apr-15-26	Initiated	Citigroup	Buy
Feb-23-26	Upgrade	Robert W. Baird	Neutral → Outperform
Dec-09-25	Initiated	Barclays	Overweight
Aug-26-25	Upgrade	Evercore ISI	In-line → Outperform
Jul-25-25	Downgrade	Stifel	Buy → Hold
Jul-14-25	Downgrade	Robert W. Baird	Outperform → Neutral
Feb-14-25	Initiated	Wells Fargo	Equal Weight
Jan-06-25	Upgrade	BofA Securities	Underperform → Buy
Dec-04-24	Initiated	Mizuho	Neutral
Jul-22-24	Upgrade	Robert W. Baird	Neutral → Outperform
Feb-26-24	Initiated	Leerink Partners	Market Perform
Dec-12-23	Upgrade	JP Morgan	Neutral → Overweight
Nov-10-23	Upgrade	Stifel	Hold → Buy
Aug-08-22	Upgrade	UBS	Sell → Neutral
Jul-21-22	Downgrade	Goldman	Buy → Neutral
Jun-14-22	Downgrade	Robert W. Baird	Outperform → Neutral
May-13-22	Resumed	Credit Suisse	Outperform
Jan-31-22	Initiated	Morgan Stanley	Underweight
Jan-07-22	Upgrade	Credit Suisse	Neutral → Outperform
Oct-01-21	Resumed	Credit Suisse	Neutral
Feb-08-21	Resumed	Piper Sandler	Overweight
Jan-04-21	Upgrade	Robert W. Baird	Neutral → Outperform
Nov-03-20	Upgrade	Barrington Research	Mkt Perform → Outperform
May-06-20	Downgrade	Barrington Research	Outperform → Mkt Perform
Apr-07-20	Upgrade	Goldman	Neutral → Buy
Apr-02-20	Upgrade	Wolfe Research	Peer Perform → Outperform
Jan-09-20	Downgrade	BofA/Merrill	Neutral → Underperform
Jan-02-20	Upgrade	Evercore ISI	Underperform → In-line
Aug-07-19	Downgrade	William Blair	Outperform → Mkt Perform
May-30-19	Initiated	Wolfe Research	Underperform
May-15-19	Downgrade	SVB Leerink	Outperform → Mkt Perform
Apr-18-19	Initiated	Guggenheim	Buy
Jan-17-19	Initiated	UBS	Sell
Jan-03-19	Downgrade	Evercore ISI	In-line → Underperform
Jan-02-19	Downgrade	Robert W. Baird	Outperform → Neutral
Nov-08-18	Reiterated	Barrington Research	Outperform
Oct-25-18	Downgrade	Edward Jones	Hold → Sell
Oct-19-18	Resumed	Goldman	Neutral
Oct-04-18	Reiterated	Robert W. Baird	Outperform
Aug-07-18	Reiterated	Stifel	Hold
Apr-24-18	Downgrade	Goldman	Buy → Neutral
Apr-04-18	Upgrade	Leerink Partners	Mkt Perform → Outperform

View All

Henry Schein Inc Stock (HSIC) Latest News

May 15, 2026

Analysts Offer Insights on Healthcare Companies: Henry Schein (HSIC), Insulet (PODD) and Gilead Sciences (GILD) - The Globe and Mail

May 15, 2026

An Insider Of Henry Schein Picks Up 100% More Stock - simplywall.st

May 15, 2026

5 Must-Read Analyst Questions From Henry Schein’s Q1 Earnings Call - Yahoo Finance

May 15, 2026

Why Henry Schein (HSIC) is a top value stock for the long term - MSN

May 15, 2026

May 14, 2026